Charming Medical AAQS
The The AAQS of Charming Medical (MCTA) as of Oct 20, 2026 is 2. In the previous year, The AAQS was 2.00 — a change of 0.00% (lower).
Get this data via API
Financial Data API
AAQS
2
YoY
0.00%
Last updated:
Charming Medical has a current AAQS of 2.
A high AAQS can be seen as a positive indicator that the company is developing successfully.
Investors can assume that the company is on a good path to generate profits.
On the other hand, it is important to consider the AAQS of the stock Charming Medical in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.
In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.
A high AAQS can be seen as a positive indicator that the company is developing successfully.
Investors can assume that the company is on a good path to generate profits.
On the other hand, it is important to consider the AAQS of the stock Charming Medical in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.
In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.
The Charming Medical AAQS history
3 Years
10 Years
25 Years
Max
AAQS
Date
AAQS
Jan 1, 2023
2.00 USD
Jan 1, 2024
2.00 USD
Jan 1, 2025
2.00 USD
Jan 1, 2026
2.00 USD
| YEAR | AAQS | YoY |
|---|---|---|
| 2 | 0.00% | |
| 2 | 0.00% | |
| 2 | 0.00% | |
| 2 | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Charming Medical Stock analysis
What does Charming Medical do? Charming Medical Ltd generates revenue through beauty, wellness, and postpartum services utilizing traditional Chinese medicine approaches, including womb-warming therapy, BTS pelvic detox therapy, agarwood moxibustion treatment, and TCM-inspired prenatal massages. The company also sells TCM-inspired supplement products such as home herbal uterine care patches, probiotic intimate wash, and Yin nourishing pill sets. Additionally, Charming Medical Ltd provides TCM-inspired therapy technical training, dietary therapy training, and consultancy services to beauty salons, massage centers, and similar entities.
The primary buyers of these services and products are individuals seeking beauty, wellness, and postpartum care through traditional Chinese medicine methods. Beauty salons, massage centers, and similar entities purchase the training and consultancy services to enhance their offerings. The company’s product portfolio includes specific TCM-inspired items like home herbal uterine care patches and Yin nourishing pill sets, which are sold directly to consumers.
Charming Medical Ltd targets consumers interested in holistic health solutions using traditional Chinese medicine, with a focus on postpartum care and beauty enhancement. Its training services cater to businesses in the beauty and wellness industry looking to integrate TCM practices into their services. The company’s revenue streams are diversified across service provision, product sales, and professional training, all aligned with TCM-inspired wellness concepts. Charming Medical is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Charming Medical stock
The AAQS of Charming Medical is 2 in 2026.
On Eulerpool you can find the complete historical development of The AAQS Charming Medical since 2006 – with annual values, charts, and detailed analysis.
The AAQS is a key figure developed by AlleAktien.
The AAQS is a key figure developed by AlleAktien.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Quality — Charming Medical
All Key Metrics — Charming Medical
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth